Evidence map›Paper›PMID 25373145›Full record

ArticleGenome research2014

Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.

Patrick Essletzbichler, Tomasz Konopka, Federica Santoro, Doris Chen, Bianca V Gapp, Robert Kralovics, Thijn R Brummelkamp, Sebastian M B Nijman, Tilmann Bürckstümmer

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 284 citations in OpenAlex.

  1. Article
  2. Article
  3. Gigabase-scale deletion scanning of the human genome.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A metabolic cell death program downstream of SARM1 couples NADProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The design and engineering of synthetic genomes.Nature reviews. Genetics · 2025
    Review
  14. Isolation and characterization of haploid heterothallic beer yeasts.Applied microbiology and biotechnology · 2025
    Article
  15. Article
  16. Generation of Monosomy 21q Human iPS Cells by CRISPR/Cas9-Mediated Interstitial Megabase Deletion.Genes to cells : devoted to molecular & cellular mechanisms · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Patrick EssletzbichlerHaplogen GmbH, 1030 Vienna, Austria;
Tomasz KonopkaResearch Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), 1090 Vienna, Austria;
Federica SantoroHaplogen GmbH, 1030 Vienna, Austria;
Doris ChenResearch Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), 1090 Vienna, Austria;
Bianca V GappResearch Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), 1090 Vienna, Austria;
Robert KralovicsResearch Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), 1090 Vienna, Austria;
Thijn R BrummelkampResearch Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), 1090 Vienna, Austria; The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Sebastian M B NijmanHaplogen GmbH, 1030 Vienna, Austria; Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), 1090 Vienna, Austria;
Tilmann BürckstümmerHaplogen GmbH, 1030 Vienna, Austria;
Austrian Academy of Sciences · ATVienna Consulting Engineers (Austria) · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Near-haploid human cell lines are instrumental for genetic screens and genome engineering as gene inactivation is greatly facilitated by the absence of a second gene copy. However, no completely haploid human cell line has been described, hampering the genetic accessibility of a subset of genes. The near-haploid human cell line HAP1 contains a single copy of all chromosomes except for a heterozygous 30-megabase fragment of Chromosome 15. This large fragment encompasses 330 genes and is integrated on the long arm of Chromosome 19. Here, we employ a CRISPR/Cas9-based genome engineering strategy to excise this sizeable chromosomal fragment and to efficiently and reproducibly derive clones that retain their haploid state. Importantly, spectral karyotyping and single-nucleotide polymorphism (SNP) genotyping revealed that engineered-HAPloid (eHAP) cells are fully haploid with no gross chromosomal aberrations induced by Cas9. Furthermore, whole-genome sequence and transcriptome analysis of the parental HAP1 and an eHAP cell line showed that transcriptional changes are limited to the excised Chromosome 15 fragment. Together, we demonstrate the feasibility of efficiently engineering megabase deletions with the CRISPR/Cas9 technology and report the first fully haploid human cell line.

Indexed as

HaploidySequence DeletionCell LineCRISPR-Cas SystemsGene Expression ProfilingGenetic EngineeringGenomicsHumansKaryotype

Identifiers

PMID25373145
PMCPMC4248322
OpenAlexW2118967129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.